4.3 Article

Myeloid derived suppressor cells are numerically, functionally and phenotypically different in patients with multiple myeloma

Related references

Note: Only part of the references are listed.
Article Cell Biology

Blood CD33(+)HLA-DR(-) myeloid-derived suppressor cells are increased with age and a history of cancer

Chris P. Verschoor et al.

JOURNAL OF LEUKOCYTE BIOLOGY (2013)

Review Biotechnology & Applied Microbiology

Therapeutic opportunities for manipulating TReg cells in autoimmunity and cancer

Harald von Boehmer et al.

NATURE REVIEWS DRUG DISCOVERY (2013)

Review Immunology

The Role of Regulatory T Cells and TH17 Cells in Multiple Myeloma

Walter M. T. Braga et al.

CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2012)

Article Dermatology

Regulatory T Cells Stimulate B7-H1 Expression in Myeloid-Derived Suppressor Cells in ret Melanomas

Taku Fujimura et al.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2012)

Article Multidisciplinary Sciences

Osteoclasts in Multiple Myeloma Are Derived from Gr-1+CD11b+Myeloid-Derived Suppressor Cells

Junling Zhuang et al.

PLOS ONE (2012)

Review Immunology

Myeloid-derived suppressor cells as regulators of the immune system

Dmitry I. Gabrilovich et al.

NATURE REVIEWS IMMUNOLOGY (2009)

Review Immunology

Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells

Ilaria Marigo et al.

IMMUNOLOGICAL REVIEWS (2008)